MedTrace Logo

A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism

NCT02563834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2016-08-31

Study results available
· View outcomes & findings →

Summary

Studies of myocardial fuel selection using a novel palmitate-based PET probe

Conditions

Interventions

DRUG

thiapalmitate tracer

Radiolabeled tracer infusion; occurs in all treatment arms

DRUG

Saline

Saline infusion for control

DRUG

Insulin

Insulin infusion for insulin/glucose clamp procedure

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Kieren J Mather, MD · Indiana University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02563834 on ClinicalTrials.gov